The order is to deliver a continuous solid dosage production platform, including continuous blending, wet granulation and drying, dry granulation and direct compression. In addition to the Courtoy™ MODUL™ tablet press and a tablet relaxation module, the system will also include the first commercial continuous GEA coater. The entire line will be equipped with a range of PAT instruments (partly based on the GEA’s patented Lighthouse Probe™ technology) for on-line measurement of particle size distribution, humidity, blend/content uniformity and coating quality. This data will be captured in an overall control and information system which allows for ‘real-time-release’ of the finished tablets.
Jan Vugts, Managing Director of GEA Pharma Systems in Wommelgem, Belgium said, “We were all delighted to receive the order. GEA has many years’ experience with continuous processing in other industries and GPS is a market leader in batch granulation, drying and compression technologies for the pharma industry. I believe this experience and the expertise of the team in our global competence centre near Antwerp, Belgium have greatly contributed to the confidence this customer has shown in GPS.”
GEA Pharma Systems has been the leader in continuous processing technology since the introduction of ConsiGma™ in 2008 and has supplied over 15 production systems in the market.
All editorial enquiries to:
Steve Jordan
The Words Workshop Ltd
26 Swanwick Lane, Broughton,
Milton Keynes, MK10 9LD
Tel: +44 1908 695500
Email: steve@thewordsworkshop.co.uk
Web: www.thewordsworkshop.co.uk
All business enquiries to:
Kris Schoeters – Product Manager Continuous Processing
GEA Pharma Systems
Keerbaan 70, B-2160 Wommelgem, Belgium
Tel: +32 3 350 12 88
Fax: +32 3 353 20 55
E-mail: kris.schoeters@gea.com
Web: www.geapharmasystems.com
About GEA Pharma Systems
GEA Pharma Systems unites the technologies of Aeromatic-Fielder™, Buck™, Collette™, Courtoy™, Diessel™, and Lyophil™ to provide advanced one-stop solutions for solid and liquid dosage processing to the global pharmaceutical industry.
